Representing Dr. Vince Clinical Research, Dr. Toni Grant, Director of Pharmacokinetics, presented “Optimizing Pharmacokinetics in Clinical Development” at the American Society for Clinical Pharmacology & Therapeutics (ASCPT) 2025 Annual Meeting in Washington, D.C....
Dr. Vince Clinical Research is a trusted contract research organization (CRO) for human abuse potential (HAP) trials. We understand the importance of early and consistent engagement with the FDA’s Controlled Substances Staff (CSS) to maintain regulatory compliance and...
Experience Dr. George Atiee of Dr. Vince Clinical Research presenting “Medical Monitoring Oversight and Real-Time Data Access,” where he highlights the significance of accessing safety data and its ongoing analysis through remote accessible devices. This presentation...
As a leading contract research organization (CRO) for human abuse potential (HAP) trials, Dr. Vince Clinical Research has expertise in the creation and implementation of positive control groups. By following well-defined protocols, DVCR produces optimized results for...
As the leading CRO for Human Abuse Potential (HAP) studies, Dr. Vince Clinical Research has significant operational expertise in the conduct of these complex clinical trials where volunteer safety is paramount. Our clinical safety team is comprised of Advanced...
Dr. Vince Clinical Research operates the ideal clinical site for Human Abuse Potential (HAP) studies. One feature of this facility is the on-site cGMP Pharmacy, built to comply with DEA standards, which is required to source the majority of reference or comparator...
Recent Comments